Delivery Order SPE2DB20D3103-SPE2DB22FP1D2
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,351.94 Firm Fixed Price delivery order contract is for the supply of ORENCIA 125 MG/ML SYRINGEML, a specialty pharmaceutical product. The contract has an ultimate completion date of June 28, 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,004.28 firm fixed-price delivery order is for the supply of ORENCIA 125 MG/ML SYRINGEML, a specialty medication. The contract has a performance period through July 2, 2024 and does not have a set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,344.02 firm-fixed-price delivery order is for the supply of ORENCIA 125 MG/ML syringes. The contract has an ultimate completion date of January 14, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,724.52 Firm Fixed Price Delivery Order contract is for the supply of ORENCIA 125 MG/ML SYRINGEML, a specialty pharmaceutical product. The contract has an ultimate completion date of May 22, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,726.75 firm fixed-price delivery order is for the supply of ORENCIA 125 MG/ML SYRINGEML, a specialty medication. The contract has an ultimate completion date of March 19, 2025 and was awarded on March 18, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $29,215.44 Firm Fixed Price delivery order is for the supply of ORENCIA 125 MG/ML SYRINGE/ML, a specialty medication, to support military healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
- This federal contract award, valued at $8,538.39, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of ORENCIA 125 MG/ML SYRINGEML, a specialty medication. The contract has an ultimate completion date of February 13, 2025 and is a firm fixed-price arrangement. It is not designated as a set-aside contract, indicating open competition....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,141.26 firm fixed-price delivery order covers the provision of ORENCIA 125 MG/ML SYRINGEML, a specialty medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $32,251.07 Firm Fixed Price Delivery Order is for the supply of ORENCIA 125 MG/ML SYRINGEML, a specialty medication. The contract has an ultimate completion date of November 18, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award, valued at $101,799.29, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of ORENCIA 125 MG/ML SYRINGEML, a specialty medication. The award has an ultimate completion date of November 28, 2023 and a firm fixed price pricing type. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued at...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB22FP1D2Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,832.97 firm-fixed-price delivery order is for the supply of ORENCIA 125 MG/ML syringes and was awarded on July 6, 2022 with a completion date of July 7, 2022. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. In addition to the DLA contract, AmerisourceBergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 7/6/22 |